Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Acetylcysteine and Ascorbic Acid on the Prevention of Radiographic-contrast-agent Induced Reduction in Renal Function in ICU Patients.

NCT01017796 is registered in ClinicalTrials.gov with University of Thessaly as lead sponsor.

NCT NCT01017796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01017796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Acetylcysteine and Ascorbic Acid on the Prevention of Radiographic-contrast-agent Induced Reduction in Renal Function in ICU Patients.
Lead sponsor
University of Thessaly
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2009
Completion date
June 30, 2010
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contrast induced nephropathy